Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Leukoencephalopathy after cisplatin therapy.

W Brück1, E Heise, R L Friede

  • 1Department of Neuropathology, University of Göttingen, FRG.

Clinical Neuropathology
|November 1, 1989
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

An autoantibody signature predictive for multiple sclerosis: evidence at the protein level and association with histopathological lesion types.

Journal of neurology·2026
Same author

Targeting myelin lipid metabolism as a potential therapeutic strategy in a model of CMT1A neuropathy.

Nature communications·2018
Same author

B cells in multiple sclerosis therapy-A comprehensive review.

Acta neurologica Scandinavica·2018
Same author

Pattern II and pattern III MS are entities distinct from pattern I MS: evidence from cerebrospinal fluid analysis.

Journal of neuroinflammation·2017
Same author

Primary central nervous system vasculitis and its mimicking diseases - clinical features, outcome, comorbidities and diagnostic results - A case control study.

Clinical neurology and neurosurgery·2017
Same author

Brain iron accumulation in Wilson disease: a post mortem 7 Tesla MRI - histopathological study.

Neuropathology and applied neurobiology·2016
Same journal

Postmortem cerebellar and brainstem alterations in episodic ataxia type 1 and 2: Expanding the clinicopathological spectrum.

Clinical neuropathology·2026
Same journal

From genes to neuropathology: Integrative perspectives on the spectrum of spinocerebellar ataxias.

Clinical neuropathology·2026
Same journal

Progressive multifocal leukoencephalopathy as the first presentation of an underlying lymphoproliferative disorder.

Clinical neuropathology·2026
Same journal

Rapid polymer-based immunohistochemistry for intraoperative CNS tumor diagnosis: A validation study.

Clinical neuropathology·2026
Same journal

Clinical Neuropathology 2-2026.

Clinical neuropathology·2026
Same journal

Neuronal and glial intranuclear inclusions in a patient with oculopharyngodistal myopathy associated with noncoding GGC repeat expansions in <i>GIPC1</i>.

Clinical neuropathology·2026
See all related articles

Cisplatin chemotherapy can cause brain damage. A patient with oropharynx cancer developed necrotizing leukoencephalopathy, a demyelinating brain condition, after cisplatin treatment.

Area of Science:

  • Neuroscience
  • Oncology
  • Toxicology

Background:

  • Cisplatin is a widely used chemotherapeutic agent for various cancers.
  • Cisplatin is known to cause neurotoxicity, primarily manifesting as peripheral neuropathy and ototoxicity.

Observation:

  • A patient with oropharynx carcinoma received cisplatin-based chemotherapy.
  • The patient subsequently developed an unusual neurological condition.

Findings:

  • The patient presented with multifocal, necrotizing leukoencephalopathy, a rare form of brain white matter damage.
  • This condition involved demyelination and tissue death in the cerebrum's white matter.

Implications:

  • Cisplatin can induce demyelinating and necrotizing lesions in the brain's white matter.

Related Experiment Videos

  • This expands the known spectrum of cisplatin-induced neurotoxicity beyond peripheral nerves and the auditory system.
  • Further research is needed to understand the mechanisms and potential management of this severe neurological side effect.